Antioxidant supplement NAC tested for MS brain health
NCT ID NCT03032601
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether N-acetyl cysteine (NAC), a common antioxidant supplement, can improve brain function and reduce inflammation in people with multiple sclerosis (MS). Researchers will use brain scans to measure changes in metabolism and inflammation. The study enrolls 55 adults with MS who are not planning to start new medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- N-acetyl cysteine (NAC)
- What this could lead to
- If it works, this could point toward a simple supplement to support brain health and reduce inflammation in multiple sclerosis.
- What could go wrong
- This is a small, early-stage study with no placebo control. NAC is generally safe, but benefits may be modest or not seen at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?